Sovicille, Italy

Stefano Viti


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stefano Viti

Introduction

Stefano Viti is a notable inventor based in Sovicille, Italy. He has made significant contributions to the field of immunology through his innovative research and development of conjugate compounds. His work focuses on enhancing immune responses, which has important implications for vaccine development.

Latest Patents

Stefano Viti holds a patent for "Conjugates formed from heat shock proteins and oligo- or polysaccharides." This invention provides conjugate compounds that include at least one heat shock protein or a portion thereof, which contains at least one immunostimulatory domain and at least one capsular oligosaccharide or polysaccharide derived from pathogenic bacteria. The compounds specifically comprise oligosaccharides from the Meningococci C (MenC) group and heat shock proteins such as BCG GroE1-type 65 kDa hsp (hspR65) and recombinant DnaK-type 70 kDa hsp (hspR70). The patent also outlines processes for producing these conjugate compounds, as well as pharmaceutical and therapeutic compositions that utilize them.

Career Highlights

Stefano Viti has had a distinguished career, primarily working with Chiron S.p.a., a company known for its focus on biotechnology and vaccine development. His innovative work has contributed to advancements in the field, particularly in the area of immune response induction.

Collaborations

Throughout his career, Stefano has collaborated with esteemed colleagues such as Rino Rappuoli and Paolo Costantino. These collaborations have further enhanced the impact of his research and innovations in immunology.

Conclusion

Stefano Viti's contributions to the field of immunology through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development and immune response therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…